Review



quantinova pathogen ic kit  (Qiagen)


Bioz Verified Symbol Qiagen is a verified supplier
Bioz Manufacturer Symbol Qiagen manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Qiagen quantinova pathogen ic kit
    Quantinova Pathogen Ic Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 94/100, based on 52 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pathogen/QuantiNova+Pathogen+%2BIC+Kit/pmc08421586-73-25-32
    Average 94 stars, based on 52 article reviews
    quantinova pathogen ic kit - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    other:

    Article Title: Chasing intermediate hosts of Echinococcus multilocularis at the southern edge of its European distribution using red fox stomach content analysis
    Article Snippet: Nucleotide sequences were analysed with the Basic Local Alignment Search Tool (BLAST; https://blast.ncbi.nlm.nih.gov/Blast.cgi ) on NCBI (National Centre for Biotechnology Information) platform.

    Article Title: A Severe Clinical Case of Ehrlichia canis and Toxoplasma gondii in a Dog (With the First Morphological Detection of Tachyzoites in Peripheral Blood).
    Article Snippet: For specific DNA detection, the QuantiNova Pathogen+IC kit (Qiagen, Hilden, Germany) was used according to the manufacturer’s instructions, in combination with commercially available primers and probes (Omnigen SRL, Romania).

    Article Title: A Severe Clinical Case of Ehrlichia canis and Toxoplasma gondii in a Dog (With the First Morphological Detection of Tachyzoites in Peripheral Blood)
    Article Snippet: For specific DNA detection, the QuantiNova Pathogen+IC kit (Qiagen, Hilden, Germany) was used according to the manufacturer's instructions, in combination with commercially available primers and probes (Omnigen SRL, Romania).

    Quantitative RT-PCR:

    Article Title: Antiviral and immunomodulatory effect of zapnometinib in animal models and hospitalized COVID-19 patients
    Article Snippet: Briefly, viral nucleic acid extraction was performed using a QIAamp Viral RNA Mini Kit (QIAGEN, Hilden, Germany) following the manufacturer’s instructions. .. A TaqMan-based RT-qPCR assay was carried out using QuantiNova Pathogen kit (QIAGEN, Hilden, Germany) with specific primers targeting the SARS-CoV-2 N gene ( ). ..

    Real-time Polymerase Chain Reaction:

    Article Title: Multimodal Diagnosis of Canine Leishmaniosis in a Dog Relocated from Italy to Romania: A Case Report
    Article Snippet: .. The reaction was prepared in a final volume of 20 μL, consisting of 5 μL of real-time PCR master mix (QuantiNova Pathogen + IC Kit, Qiagen, Hilden, Germany), 7 μL of extracted DNA and 8 μL of the commercial primer/probe mixture. ..

    Amplification:

    Article Title: One-year surveillance of last-resort antimicrobial resistance patterns in carbapenemase-producing Klebsiella pneumoniae strains isolated in a Romanian tertiary care hospital: a prospective study
    Article Snippet: .. For nucleic acid amplification/detection, the QuantiNova Pathogen+IC kit (Qiagen, Hilden, Germany) was used, according to the manufacturer's recommendations. ..

    Article Title: Monitoring the health of wolves ( Canis lupus ): Integrating conservation and public health
    Article Snippet: Finally, 200 μl of the sample and 9 μl of internal control (QuantiNova Internal Control DNA – QIAGEN) were extracted using the Hamilton Microlab® STAR automated extractor (HAMILTON), following the protocol of the MagMAXTM Viral/Pathogen Nucleic Acid Isolation Kit (QIAGEN). .. The extracted DNA was amplified using a real-time duplex assay for the identification of E. granulosus [ ] and E. multilocularis [ ], employing the QuantiNova® Pathogen+IC Kit (QIAGEN). ..

    Reverse Transcription Polymerase Chain Reaction:

    Article Title: Impact of hepatitis C virus genotype on the efficacy of the direct-acting antivirals in chronic kidney disease patients in West Bengal, India
    Article Snippet: Viral RNA was isolated from 140 μl of HCV sero-reactive serum samples using a QIAamp viral RNA mini kit (Qiagen, Hilden, Germany), eluted in 50 μl elution buffer, and stored at -80o C. The HCV RNA was determined quantitatively based on 5‘ UTR using Real-time PCR. .. A Quanti-Fast Pathogen RT-PCR + IC kit (Qiagen, Hilden,Germany) was used to determine HCV viral RNA quantitatively. ..



    Similar Products

    94
    Zymo Research quick dna rna pathogen miniprep kit
    (A) Schematic overview of the protocol modifications incorporated into Rapid-RPIP v1 relative to the Standard RPIP workflow. Individual optimisation steps, selected to reduce turnaround time, and their estimated time savings are shown. (B) Relative abundance (%) of the ten ZymoBIOMICS-DNA/RNA mock community organisms recovered by two extraction methods <t>(Quick-DNA/RNA,</t> ZymoBIOMICS-DNA/RNA; mean of 2 replicates each) compared with the manufacturer theoretical composition. (C) RPKM concordance between standard and rapid cDNA synthesis protocols for RNA respiratory viruses (n = 6 organism–sample pairs). Dashed line: identity (y = x); solid line: linear regression with 95% CI. Spearman ρ and Pearson r (log₁₀-RPKM) annotated. (D) Coefficient of variation (log₁₀ scale) of RPKM values across three hybridisation times (30/60/90 min), grouped by pathogen type (Bacteria, RNA Virus, DNA Virus); n per group annotated.
    Quick Dna Rna Pathogen Miniprep Kit, supplied by Zymo Research, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pathogen/Quick-DNA%2FRNA+Pathogen+Miniprep/med_rxiv__64898__2026__10__09__26365131-50-16-20
    Average 94 stars, based on 1 article reviews
    quick dna rna pathogen miniprep kit - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    99
    Envigo pathogen free c57bl 6j olahsd immune competent female mice
    (A) Schematic overview of the protocol modifications incorporated into Rapid-RPIP v1 relative to the Standard RPIP workflow. Individual optimisation steps, selected to reduce turnaround time, and their estimated time savings are shown. (B) Relative abundance (%) of the ten ZymoBIOMICS-DNA/RNA mock community organisms recovered by two extraction methods <t>(Quick-DNA/RNA,</t> ZymoBIOMICS-DNA/RNA; mean of 2 replicates each) compared with the manufacturer theoretical composition. (C) RPKM concordance between standard and rapid cDNA synthesis protocols for RNA respiratory viruses (n = 6 organism–sample pairs). Dashed line: identity (y = x); solid line: linear regression with 95% CI. Spearman ρ and Pearson r (log₁₀-RPKM) annotated. (D) Coefficient of variation (log₁₀ scale) of RPKM values across three hybridisation times (30/60/90 min), grouped by pathogen type (Bacteria, RNA Virus, DNA Virus); n per group annotated.
    Pathogen Free C57bl 6j Olahsd Immune Competent Female Mice, supplied by Envigo, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pathogen/C57BL%2F6+aged+inbred+mice/10__22203_slash_ecm__v033a11-101-1-8
    Average 99 stars, based on 1 article reviews
    pathogen free c57bl 6j olahsd immune competent female mice - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Inotiv pathogen free spf c57bl 6
    ABXs can promote HCC in vivo and reshape the myeloid liver tumor immune microenvironment in tumors presenting OVA model antigens. (A) Schematic of the experimental design of in vivo ABXs treatment experiments performed in C57BL/6 WT mice. Generated by BioRender. (B) Quantification of MYC-lucOS;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (C) Liver-to-body weight ratio of the 5 treatment groups. (D) Survival curve in mice harboring MYC-lucOS;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). (E) Quantification of the number of myeloid subpopulations including Kupffer cells (KCs), monocytes, Mono/Macs, tumor-associated macrophages (TAMs), total dendritic cells (DCs), cDC1, and cDC2 in the livers of the corresponding mice (n=4–5 per group). (F) Quantification of MYC-luc;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (G) Liver-to-body weight ratio of the 5 treatment groups. (H) Survival curve in mice harboring MYC-luc;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). Abbreviations: ABXs, antibiotics; DCs, dendritic cells; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; KCs, Kupffer cells; Mono/Mac, monocyte/macrophage; OVA, ovalbumin; TAMS, tumor-associated macrophages; WT, wild type.
    Pathogen Free Spf C57bl 6, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pathogen/C57BL%2F6+Mouse/pmc13766593-54-1-11
    Average 99 stars, based on 1 article reviews
    pathogen free spf c57bl 6 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    90
    ATCC non pathogenic strain s epidermidis atcc
    ABXs can promote HCC in vivo and reshape the myeloid liver tumor immune microenvironment in tumors presenting OVA model antigens. (A) Schematic of the experimental design of in vivo ABXs treatment experiments performed in C57BL/6 WT mice. Generated by BioRender. (B) Quantification of MYC-lucOS;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (C) Liver-to-body weight ratio of the 5 treatment groups. (D) Survival curve in mice harboring MYC-lucOS;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). (E) Quantification of the number of myeloid subpopulations including Kupffer cells (KCs), monocytes, Mono/Macs, tumor-associated macrophages (TAMs), total dendritic cells (DCs), cDC1, and cDC2 in the livers of the corresponding mice (n=4–5 per group). (F) Quantification of MYC-luc;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (G) Liver-to-body weight ratio of the 5 treatment groups. (H) Survival curve in mice harboring MYC-luc;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). Abbreviations: ABXs, antibiotics; DCs, dendritic cells; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; KCs, Kupffer cells; Mono/Mac, monocyte/macrophage; OVA, ovalbumin; TAMS, tumor-associated macrophages; WT, wild type.
    Non Pathogenic Strain S Epidermidis Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pathogen/Ostracoblabe+implexa+Bornet+et+Flahault/pm42983663-21-1-5
    Average 90 stars, based on 1 article reviews
    non pathogenic strain s epidermidis atcc - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    94
    DSMZ bacterial strains bacterial strain description source pectobacterium carotovorum subsp carotovorum pcc21 soft rot pathogen
    ABXs can promote HCC in vivo and reshape the myeloid liver tumor immune microenvironment in tumors presenting OVA model antigens. (A) Schematic of the experimental design of in vivo ABXs treatment experiments performed in C57BL/6 WT mice. Generated by BioRender. (B) Quantification of MYC-lucOS;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (C) Liver-to-body weight ratio of the 5 treatment groups. (D) Survival curve in mice harboring MYC-lucOS;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). (E) Quantification of the number of myeloid subpopulations including Kupffer cells (KCs), monocytes, Mono/Macs, tumor-associated macrophages (TAMs), total dendritic cells (DCs), cDC1, and cDC2 in the livers of the corresponding mice (n=4–5 per group). (F) Quantification of MYC-luc;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (G) Liver-to-body weight ratio of the 5 treatment groups. (H) Survival curve in mice harboring MYC-luc;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). Abbreviations: ABXs, antibiotics; DCs, dendritic cells; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; KCs, Kupffer cells; Mono/Mac, monocyte/macrophage; OVA, ovalbumin; TAMS, tumor-associated macrophages; WT, wild type.
    Bacterial Strains Bacterial Strain Description Source Pectobacterium Carotovorum Subsp Carotovorum Pcc21 Soft Rot Pathogen, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pathogen/Pectobacterium+carotovorum/10__5423_slash_ppj__oa__08__2026__0123-81-0-41
    Average 94 stars, based on 1 article reviews
    bacterial strains bacterial strain description source pectobacterium carotovorum subsp carotovorum pcc21 soft rot pathogen - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    99
    Inotiv specific pathogen free cba caolahsd cba
    ABXs can promote HCC in vivo and reshape the myeloid liver tumor immune microenvironment in tumors presenting OVA model antigens. (A) Schematic of the experimental design of in vivo ABXs treatment experiments performed in C57BL/6 WT mice. Generated by BioRender. (B) Quantification of MYC-lucOS;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (C) Liver-to-body weight ratio of the 5 treatment groups. (D) Survival curve in mice harboring MYC-lucOS;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). (E) Quantification of the number of myeloid subpopulations including Kupffer cells (KCs), monocytes, Mono/Macs, tumor-associated macrophages (TAMs), total dendritic cells (DCs), cDC1, and cDC2 in the livers of the corresponding mice (n=4–5 per group). (F) Quantification of MYC-luc;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (G) Liver-to-body weight ratio of the 5 treatment groups. (H) Survival curve in mice harboring MYC-luc;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). Abbreviations: ABXs, antibiotics; DCs, dendritic cells; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; KCs, Kupffer cells; Mono/Mac, monocyte/macrophage; OVA, ovalbumin; TAMS, tumor-associated macrophages; WT, wild type.
    Specific Pathogen Free Cba Caolahsd Cba, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pathogen/C57BL%2F6+Mouse/pm42980774-29-5-12
    Average 99 stars, based on 1 article reviews
    specific pathogen free cba caolahsd cba - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    94
    DSMZ fungal pathogens botrytis cinerea
    ABXs can promote HCC in vivo and reshape the myeloid liver tumor immune microenvironment in tumors presenting OVA model antigens. (A) Schematic of the experimental design of in vivo ABXs treatment experiments performed in C57BL/6 WT mice. Generated by BioRender. (B) Quantification of MYC-lucOS;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (C) Liver-to-body weight ratio of the 5 treatment groups. (D) Survival curve in mice harboring MYC-lucOS;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). (E) Quantification of the number of myeloid subpopulations including Kupffer cells (KCs), monocytes, Mono/Macs, tumor-associated macrophages (TAMs), total dendritic cells (DCs), cDC1, and cDC2 in the livers of the corresponding mice (n=4–5 per group). (F) Quantification of MYC-luc;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (G) Liver-to-body weight ratio of the 5 treatment groups. (H) Survival curve in mice harboring MYC-luc;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). Abbreviations: ABXs, antibiotics; DCs, dendritic cells; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; KCs, Kupffer cells; Mono/Mac, monocyte/macrophage; OVA, ovalbumin; TAMS, tumor-associated macrophages; WT, wild type.
    Fungal Pathogens Botrytis Cinerea, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pathogen/Botrytis+cinerea/pm42913464-47-1-33
    Average 94 stars, based on 1 article reviews
    fungal pathogens botrytis cinerea - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    99
    ATCC human pathogenic microorganisms bacillus subtilis
    Biological properties of dictamnine.
    Human Pathogenic Microorganisms Bacillus Subtilis, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pathogen/Bacillus+spizizenii+(Nakamura+et+al%2E)+Dunlap+et+al/pmc13765392-101-2-7
    Average 99 stars, based on 1 article reviews
    human pathogenic microorganisms bacillus subtilis - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    ATCC antimicrobial activity against pathogenic bacteria
    Biological properties of dictamnine.
    Antimicrobial Activity Against Pathogenic Bacteria, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pathogen/Escherichia+coli+(Migula)+Castellani+and+Chalmers/10__1038_slash_s41598___026___76824___y-77-0-16
    Average 99 stars, based on 1 article reviews
    antimicrobial activity against pathogenic bacteria - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    97
    Bio-Rad western ecl substrate plos pathogens
    Biological properties of dictamnine.
    Western Ecl Substrate Plos Pathogens, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pathogen/Clarity+Max+Western+ECL+Substrate/pm42868206-236-13-12
    Average 97 stars, based on 1 article reviews
    western ecl substrate plos pathogens - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    Image Search Results


    (A) Schematic overview of the protocol modifications incorporated into Rapid-RPIP v1 relative to the Standard RPIP workflow. Individual optimisation steps, selected to reduce turnaround time, and their estimated time savings are shown. (B) Relative abundance (%) of the ten ZymoBIOMICS-DNA/RNA mock community organisms recovered by two extraction methods (Quick-DNA/RNA, ZymoBIOMICS-DNA/RNA; mean of 2 replicates each) compared with the manufacturer theoretical composition. (C) RPKM concordance between standard and rapid cDNA synthesis protocols for RNA respiratory viruses (n = 6 organism–sample pairs). Dashed line: identity (y = x); solid line: linear regression with 95% CI. Spearman ρ and Pearson r (log₁₀-RPKM) annotated. (D) Coefficient of variation (log₁₀ scale) of RPKM values across three hybridisation times (30/60/90 min), grouped by pathogen type (Bacteria, RNA Virus, DNA Virus); n per group annotated.

    Journal: medRxiv

    Article Title: Same-day hybrid capture workflow for diagnosis and surveillance of respiratory pathogens

    doi: 10.64898/2026.10.09.26365131

    Figure Lengend Snippet: (A) Schematic overview of the protocol modifications incorporated into Rapid-RPIP v1 relative to the Standard RPIP workflow. Individual optimisation steps, selected to reduce turnaround time, and their estimated time savings are shown. (B) Relative abundance (%) of the ten ZymoBIOMICS-DNA/RNA mock community organisms recovered by two extraction methods (Quick-DNA/RNA, ZymoBIOMICS-DNA/RNA; mean of 2 replicates each) compared with the manufacturer theoretical composition. (C) RPKM concordance between standard and rapid cDNA synthesis protocols for RNA respiratory viruses (n = 6 organism–sample pairs). Dashed line: identity (y = x); solid line: linear regression with 95% CI. Spearman ρ and Pearson r (log₁₀-RPKM) annotated. (D) Coefficient of variation (log₁₀ scale) of RPKM values across three hybridisation times (30/60/90 min), grouped by pathogen type (Bacteria, RNA Virus, DNA Virus); n per group annotated.

    Article Snippet: To this end, the ZymoBIOMICS DNA/RNA Miniprep Kit for nucleic acid extraction was replaced with the Quick-DNA/RNA Pathogen Miniprep Kit (Zymo Research, R1042), and samples were processed according to the manufacturer’s instructions.

    Techniques: Extraction, cDNA Synthesis, Hybridization, Bacteria, Virus

    ABXs can promote HCC in vivo and reshape the myeloid liver tumor immune microenvironment in tumors presenting OVA model antigens. (A) Schematic of the experimental design of in vivo ABXs treatment experiments performed in C57BL/6 WT mice. Generated by BioRender. (B) Quantification of MYC-lucOS;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (C) Liver-to-body weight ratio of the 5 treatment groups. (D) Survival curve in mice harboring MYC-lucOS;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). (E) Quantification of the number of myeloid subpopulations including Kupffer cells (KCs), monocytes, Mono/Macs, tumor-associated macrophages (TAMs), total dendritic cells (DCs), cDC1, and cDC2 in the livers of the corresponding mice (n=4–5 per group). (F) Quantification of MYC-luc;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (G) Liver-to-body weight ratio of the 5 treatment groups. (H) Survival curve in mice harboring MYC-luc;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). Abbreviations: ABXs, antibiotics; DCs, dendritic cells; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; KCs, Kupffer cells; Mono/Mac, monocyte/macrophage; OVA, ovalbumin; TAMS, tumor-associated macrophages; WT, wild type.

    Journal: Hepatology Communications

    Article Title: Bacteroidetes promote hepatocellular carcinoma progression and resistance to immunotherapy

    doi: 10.1097/HC9.0000000000001086

    Figure Lengend Snippet: ABXs can promote HCC in vivo and reshape the myeloid liver tumor immune microenvironment in tumors presenting OVA model antigens. (A) Schematic of the experimental design of in vivo ABXs treatment experiments performed in C57BL/6 WT mice. Generated by BioRender. (B) Quantification of MYC-lucOS;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (C) Liver-to-body weight ratio of the 5 treatment groups. (D) Survival curve in mice harboring MYC-lucOS;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). (E) Quantification of the number of myeloid subpopulations including Kupffer cells (KCs), monocytes, Mono/Macs, tumor-associated macrophages (TAMs), total dendritic cells (DCs), cDC1, and cDC2 in the livers of the corresponding mice (n=4–5 per group). (F) Quantification of MYC-luc;CTNNB1 macroscopic tumors in the livers of the 5 indicated treatment groups at 3 weeks. In the right panel, representative pictures of the mouse livers. Scale bars, 1 cm. (G) Liver-to-body weight ratio of the 5 treatment groups. (H) Survival curve in mice harboring MYC-luc;CTNNB1 tumors treated with vancomycin or without treatment (Ctrl). Abbreviations: ABXs, antibiotics; DCs, dendritic cells; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; KCs, Kupffer cells; Mono/Mac, monocyte/macrophage; OVA, ovalbumin; TAMS, tumor-associated macrophages; WT, wild type.

    Article Snippet: Specific pathogen-free (SPF) C57BL/6 wild-type mice of 4–6-week-old were purchased from Envigo.

    Techniques: In Vivo, Generated, Injection

    Parabacteroides distasonis promotes HCC in mice harboring tumors with OVA model antigens. (A) Heatmap plot of average % OTU Bacteroidetes species in ctrl and vancomycin-treated mice stools. (B) Schematic of the experimental design of the in vivo colonization with P. distasonis experiment performed in C57BL/6 WT mice. Generated by BioRender. Survival curve in SPF mice pre-treated with ABXs, colonized with P. distasonis or PBS (Ctrl-group) by oral gavage and harboring MYC-lucOS;CTNNB1 (C) or MYC-luc;CTNNB1 (D) tumors. Abbreviations: ABXs, antibiotics; FMT, fecal microbiome transplant; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; OTU, operational taxonomic unit; OVA, ovalbumin; PBS, phosphate-buffered saline; PBS-FMT, phosphate-buffered saline–fecal microbiome transplantation; SPF, specific pathogen-free; WT, wild type.

    Journal: Hepatology Communications

    Article Title: Bacteroidetes promote hepatocellular carcinoma progression and resistance to immunotherapy

    doi: 10.1097/HC9.0000000000001086

    Figure Lengend Snippet: Parabacteroides distasonis promotes HCC in mice harboring tumors with OVA model antigens. (A) Heatmap plot of average % OTU Bacteroidetes species in ctrl and vancomycin-treated mice stools. (B) Schematic of the experimental design of the in vivo colonization with P. distasonis experiment performed in C57BL/6 WT mice. Generated by BioRender. Survival curve in SPF mice pre-treated with ABXs, colonized with P. distasonis or PBS (Ctrl-group) by oral gavage and harboring MYC-lucOS;CTNNB1 (C) or MYC-luc;CTNNB1 (D) tumors. Abbreviations: ABXs, antibiotics; FMT, fecal microbiome transplant; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; OTU, operational taxonomic unit; OVA, ovalbumin; PBS, phosphate-buffered saline; PBS-FMT, phosphate-buffered saline–fecal microbiome transplantation; SPF, specific pathogen-free; WT, wild type.

    Article Snippet: Specific pathogen-free (SPF) C57BL/6 wild-type mice of 4–6-week-old were purchased from Envigo.

    Techniques: In Vivo, Generated, Microbiome, Injection, Saline, Transplantation Assay

    Fecal microbiome transplant with human microbiota enriched in Bacteroidetes promotes HCC in mice harboring tumors with OVA model antigens. (A) Taxonomic plots of phylum relative abundance (%) composition from patients’ stools collected from NR-1025 (left) and R-1014 (right) subjects from HCC “cohort A.” (B) Schematic of experiment design of survival experiments on either C57BL6 WT GF or SPF mice pre-depleted with ABXs harboring MYC-lucOS;CTNNB1 tumors after FMT with blended stool generated from an R-donor (1014 subject) and an NR-donor (1025 subject). Schematic generated by BioRender. Survival curves from ex-GF mice harboring MYC-lucOS;CTNNB1 (C) or MYC-luc;CTNNB1 (D) tumors upon FMT with 1025-stool or 1014-stool. Abbreviations: ABXs, antibiotics; FMT, fecal microbiome transplant; GF, germ-free; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; OVA, ovalbumin; SPF, specific pathogen-free; WT, wild type.

    Journal: Hepatology Communications

    Article Title: Bacteroidetes promote hepatocellular carcinoma progression and resistance to immunotherapy

    doi: 10.1097/HC9.0000000000001086

    Figure Lengend Snippet: Fecal microbiome transplant with human microbiota enriched in Bacteroidetes promotes HCC in mice harboring tumors with OVA model antigens. (A) Taxonomic plots of phylum relative abundance (%) composition from patients’ stools collected from NR-1025 (left) and R-1014 (right) subjects from HCC “cohort A.” (B) Schematic of experiment design of survival experiments on either C57BL6 WT GF or SPF mice pre-depleted with ABXs harboring MYC-lucOS;CTNNB1 tumors after FMT with blended stool generated from an R-donor (1014 subject) and an NR-donor (1025 subject). Schematic generated by BioRender. Survival curves from ex-GF mice harboring MYC-lucOS;CTNNB1 (C) or MYC-luc;CTNNB1 (D) tumors upon FMT with 1025-stool or 1014-stool. Abbreviations: ABXs, antibiotics; FMT, fecal microbiome transplant; GF, germ-free; HCC, hepatocellular carcinoma; HDTVI, hydrodynamic tail-vein injection; OVA, ovalbumin; SPF, specific pathogen-free; WT, wild type.

    Article Snippet: Specific pathogen-free (SPF) C57BL/6 wild-type mice of 4–6-week-old were purchased from Envigo.

    Techniques: Microbiome, Generated, Injection

    Biological properties of dictamnine.

    Journal: Molecules

    Article Title: Dictamnine and Related Quinoline Alkaloids from Dictamnus : From Phytochemistry to Biological Activities and Toxicity

    doi: 10.3390/molecules31213805

    Figure Lengend Snippet: Biological properties of dictamnine.

    Article Snippet: Antimicrobial , Human pathogenic microorganisms: Bacillus subtilis (ATCC 6633), Candida albicans (ATCC 10231), and Pseudomonas aeruginosa (ATCC 27853) , 8–128 μg/mL , Not investigated , Dictamnine exhibited moderate antimicrobial activity. , [ ] .

    Techniques: Activity Assay